Skip to Main Content

Anebulo Pharmaceuticals said Tuesday that a single dose of its experimental pill blunted the effects of THC, the psychoactive ingredient in marijuana, supporting further development of the medicine as a potential antidote for cannabis intoxication.

With more states legalizing marijuana and the sale of higher-potency THC products on the rise, the Austin, Texas-based company sees a medical need — and a commercial opportunity — for an easily dispensed, high-reversing treatment. The medicine could be used to help people seeking care in hospital emergency departments after they accidentally or unintentionally consume excessive amounts of cannabis or THC-containing products.


“With this initial study, our goal was to show that we could reverse the signs and symptoms of THC intoxication,” said Joe Lawler, Anebulo’s founder and chairman. “I think we have a drug. There’s a lot more work to do between today and approval, but we’re very happy with these first data.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment

There was an error saving your display name. Please check and try again.